Hos patienter > 65 år kender man ikke behandlingens gavnlige virkning i henhold til ovennævnte kriterier, da disse patienter ikke indgik i undersøgelsen.
The benefit of the treatment on the criteria indicated above is not known in patients over the age of 65 years, who were not included in the study.